康乃德生物制藥
CNTB0.68738.40% ( -0.0630 )
交易中: 11月10日 13:35:08 (美東)全部股東
股東類型
- 創投/私募28.70%
- 機構投資者23.68%
- 個人與內幕人士15.19%
- 對沖基金13.34%
- 其他19.09%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Panacea Venture Management Co., Ltd. | 21.14% | 1,331.00 萬 | 0.15% | +15.00 萬 | 29/05/2026 |
Wubin PanCo-Founder & Former Director | 9.57% | 602.68 萬 | 0.04% | +0 | 14/04/2026 |
Suzhou Xiangtang Venture Investment Limited | 7.61% | 478.98 萬 | 0.03% | +0 | 26/03/2026 |
Advantech Capital Advisors II Limited | 7.56% | 476.22 萬 | 0.03% | +0 | 21/03/2025 |
Ikarian Capital, LLC | 7.21% | 453.85 萬 | 1.39% | -85.00 萬 | 30/06/2026 |
BML Capital Management, LLC | 6.14% | 386.44 萬 | 5.23% | +329.11 萬 | 30/09/2026 |
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | 4.38% | 275.65 萬 | 3.31% | -208.44 萬 | |
Zheng WeiCo-Founder & Former Director | 4.00% | 252.04 萬 | 2.18% | -135.57 萬 | 30/06/2026 |
Eli Lilly Investment Consulting (Shanghai) Co., Ltd. | 3.85% | 242.46 萬 | 0.02% | +0 | 26/03/2026 |
683 Capital Management, LLC | 2.04% | 128.50 萬 | 0.61% | +38.50 萬 | 30/06/2026 |
Boothbay Fund Management, LLC | 1.55% | 97.37 萬 | 0.42% | -26.09 萬 | 30/06/2026 |
LAV Investment Adviser Limited | 1.45% | 91.23 萬 | <0.01% | +0 | 26/03/2026 |
BlackRock, Inc. | 1.38% | 87.17 萬 | -- | +87.17 萬 | 30/06/2026 |
Perceptive Advisors LLC | 1.26% | 79.27 萬 | <0.01% | +0 | 30/06/2026 |
ADAR1 Capital Management, LLC | 1.11% | 70.00 萬 | 0.07% | -4.24 萬 | 30/06/2026 |
Silverarc Capital Management, LLC | 0.87% | 54.50 萬 | -- | +54.50 萬 | 30/06/2026 |
Richmond Brothers, Inc. | 0.85% | 53.56 萬 | 0.09% | +5.90 萬 | 30/06/2026 |
Knott Partners Management, LLC | 0.71% | 44.49 萬 | 0.09% | +5.70 萬 | 30/06/2026 |
Braden Leonard | 0.64% | 40.00 萬 | -- | +40.00 萬 | 30/09/2026 |
Stonepine Capital Management LLC | 0.58% | 36.43 萬 | 0.08% | +5.43 萬 | 30/06/2026 |